Lauren Lohmer, PhD (she/her/hers)

Director, Quantitative Clinical Pharmacology
Indivior, Inc

Poster(s):

• (M-073) Exposure-Response Analyses for Monthly Buprenorphine Extended-Release (BUP-XR) in Patients with Opioid Use Disorder and Frequent Fentanyl Use
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT